These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide. Jacobsson SO, Fowler CJ. Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246 [Abstract] [Full Text] [Related]
7. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. Glaser ST, Deutsch DG, Studholme KM, Zimov S, Yazulla S. Vis Neurosci; 2005 Apr; 22(6):693-705. PubMed ID: 16469181 [Abstract] [Full Text] [Related]
8. Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study. Björklund E, Blomqvist A, Hedlin J, Persson E, Fowler CJ. PLoS One; 2014 Apr; 9(7):e103479. PubMed ID: 25078278 [Abstract] [Full Text] [Related]
9. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent. Nicolussi S, Chicca A, Rau M, Rihs S, Soeberdt M, Abels C, Gertsch J. Biochem Pharmacol; 2014 Dec 15; 92(4):669-89. PubMed ID: 25283614 [Abstract] [Full Text] [Related]
10. Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. Maccarrone M, Piccirilli S, Battista N, Del Duca C, Nappi G, Corasaniti MT, Finazzi-Agrò A, Bagetta G. J Neurochem; 2004 Jun 15; 89(5):1293-300. PubMed ID: 15147522 [Abstract] [Full Text] [Related]
11. Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier. Muthian S, Nithipatikom K, Campbell WB, Hillard CJ. J Pharmacol Exp Ther; 2000 Apr 15; 293(1):289-95. PubMed ID: 10734181 [Abstract] [Full Text] [Related]
15. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. Glaser ST, Gatley SJ, Gifford AN. J Pharmacol Exp Ther; 2006 Mar 15; 316(3):1088-97. PubMed ID: 16278311 [Abstract] [Full Text] [Related]
16. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. Vandevoorde S, Fowler CJ. Br J Pharmacol; 2005 Aug 15; 145(7):885-93. PubMed ID: 15895107 [Abstract] [Full Text] [Related]
17. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. Bradshaw HB, Rimmerman N, Hu SS, Benton VM, Stuart JM, Masuda K, Cravatt BF, O'Dell DK, Walker JM. BMC Biochem; 2009 May 21; 10():14. PubMed ID: 19460156 [Abstract] [Full Text] [Related]
19. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons. Price TJ, Patwardhan AM, Flores CM, Hargreaves KM. Neuropharmacology; 2005 Jul 21; 49(1):25-39. PubMed ID: 15992578 [Abstract] [Full Text] [Related]
20. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ. Br J Pharmacol; 2001 Aug 21; 133(8):1263-75. PubMed ID: 11498512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]